Real-time enrollment status for this advanced solid tumor clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 3:43 PM UTC
| NCT Number | NCT05007782 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 416 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | December 29, 2025 (Dec 29, 2025) |
As of August 27, 2026: Clinical trial NCT05007782 is currently recruiting participants. This phase1 study for advanced solid tumor is actively seeking new participants at 10 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05007782 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05007782 was last updated Dec 29, 2025 (December 29, 2025). HelloStudys verifies this status automatically.